Search research articles
Contact Us
Filters
Showing results (21-30 of 127) with videos related to
Page
of 13
Sort By:
Trends in Pharmacological Sciences
|
January 14, 2018
Regulatory Science - An Underappreciated Component of Translational Research
Rodney Rouse, Issam Zineh, David G Strauss
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 27, 2007
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease
Christina L Aquilante, Amber L Beitelshees, Issam Zineh
Pharmacotherapy
|
November 5, 2003
The evolving role of nesiritide in advanced or decompensated heart failure
Issam Zineh, Richard S Schofield, Julie A Johnson
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 1, 2006
Development and cross-validation of sequencing-based assays for genotyping common polymorphisms of the CXCL5 gene
Issam Zineh, Gregory J Welder, Taimour Y Langaee
Cardiovascular Drugs and Therapy
|
January 26, 2012
Modulatory effect of fenofibrate on endothelial production of neutrophil chemokines IL-8 and ENA-78
Elvin Tyrone Price, Gregory James Welder, Issam Zineh
Clinical Pharmacology and Therapeutics
|
March 6, 2024
The US Food and Drug Administration's Model-Informed Drug Development Meeting Program: From Pilot to Pathway
Rajanikanth Madabushi, Jessica Benjamin, Hao Zhu, et al.
Clinical Pharmacology and Therapeutics
|
February 1, 2018
Pediatric Drug Development: Outlook for Science-Based Innovation
Dionna J Green, Issam Zineh, Gilbert J Burckart
Diabetes Care
|
March 1, 2007
NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes
Issam Zineh, Amber L Beitelshees, Michael J Haller
JACC. Basic to Translational Science
|
September 4, 2018
Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
Katarzyna Drozda, Michael A Pacanowski, Christian Grimstein, et al.
Nature Reviews. Drug Discovery
|
December 23, 2017
Regulatory policy for the development of targeted therapies for low-frequency molecular subtypes of disease
Robert N Schuck, Michael Pacanowski, Janet Woodcock, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 127) with videos related to
Sort By:
Page
of 13
Trends in Pharmacological Sciences
|
January 14, 2018
Regulatory Science - An Underappreciated Component of Translational Research
Rodney Rouse, Issam Zineh, David G Strauss
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 27, 2007
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease
Christina L Aquilante, Amber L Beitelshees, Issam Zineh
Pharmacotherapy
|
November 5, 2003
The evolving role of nesiritide in advanced or decompensated heart failure
Issam Zineh, Richard S Schofield, Julie A Johnson
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 1, 2006
Development and cross-validation of sequencing-based assays for genotyping common polymorphisms of the CXCL5 gene
Issam Zineh, Gregory J Welder, Taimour Y Langaee
Cardiovascular Drugs and Therapy
|
January 26, 2012
Modulatory effect of fenofibrate on endothelial production of neutrophil chemokines IL-8 and ENA-78
Elvin Tyrone Price, Gregory James Welder, Issam Zineh
Clinical Pharmacology and Therapeutics
|
March 6, 2024
The US Food and Drug Administration's Model-Informed Drug Development Meeting Program: From Pilot to Pathway
Rajanikanth Madabushi, Jessica Benjamin, Hao Zhu, et al.
Clinical Pharmacology and Therapeutics
|
February 1, 2018
Pediatric Drug Development: Outlook for Science-Based Innovation
Dionna J Green, Issam Zineh, Gilbert J Burckart
Diabetes Care
|
March 1, 2007
NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes
Issam Zineh, Amber L Beitelshees, Michael J Haller
JACC. Basic to Translational Science
|
September 4, 2018
Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
Katarzyna Drozda, Michael A Pacanowski, Christian Grimstein, et al.
Nature Reviews. Drug Discovery
|
December 23, 2017
Regulatory policy for the development of targeted therapies for low-frequency molecular subtypes of disease
Robert N Schuck, Michael Pacanowski, Janet Woodcock, et al.
Page
of 13